Filing Details

Accession Number:
0001567619-21-012419
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-21 15:51:22
Reporting Period:
2021-06-16
Accepted Time:
2021-06-21 15:51:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX Pharmaceutical Preparations (2834) 273521219
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654058 A. Sean Mccarthy C/O Cytomx Therapeutics, Inc.
151 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-16 100,000 $7.04 93,118 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,849 Direct
Footnotes
  1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
  3. This transaction was executed in multiple trades in prices ranging from $6.88 to $7.135, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.